GlassScriptPhysician profile
Dawood Nasir
NPI 1710949599
$1,651.68
in general payments reported to CMS, 2019-2025
13 companies · $351 in 2025
The $351 reported for 2025 was more than what 88% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $117 · 2021: $121 · 2022: $122 · 2023: $530 · 2024: $411 · 2025: $351.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,292.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,291.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $458.67 | 2021-2025 | Exparel |
| Medtronic, INC. | $240.91 | 2023-2024 | Nellcor, Bis |
| Csl Behring | $224.84 | 2023-2025 | Kcentra |
| Eagle Pharmaceuticals, INC. | $124.72 | 2023 | |
| Chiesi USA, INC. | $120.23 | 2023 | Cleviprex |
| Grifols USA, LLC | $117.30 | 2019 | |
| Octapharma USA, INC. | $96.62 | 2025 | Fibryga |
| Biotronik INC. | $95.95 | 2024 | Orsiro Mission |
| Fisher & Paykel Healthcare INC | $60.42 | 2023-2024 | Fisher & Paykel Healthcare |
| Pharmacosmos Therapeutics INC. | $59.08 | 2024 | Monoferric |
| Abbott Laboratories | $22.61 | 2023 | Portico |
| Becton, Dickinson and Company | $17.72 | 2025 | Hemosphere |
| Mindray Ds USA, INC. | $12.61 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dawood Nasir listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.